Reward for persistence in substance P research

Journal article

Peer reviewed

Science (American Association for the Advancement of Science), Vol.281(5383), pp.1624-1625

1998-09-11

PMID: 9767028

Abstract

Aprepitant

Substance P - antagonists & inhibitors

Humans

Anti-Anxiety Agents - pharmacology

Morpholines - pharmacology

Depressive Disorder - drug therapy

Antidepressive Agents, Second-Generation - pharmacology

Antidepressive Agents, Second-Generation - therapeutic use

Brain - drug effects

Brain - metabolism

Animals

Substance P - metabolism

Anti-Anxiety Agents - therapeutic use

Morpholines - therapeutic use

Neurokinin-1 Receptor Antagonists

Clinical Trials, Phase II as Topic

7 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.195 Neuroendocrine & Intestinal Disorders; 1.195.578 Adrenomedullin
Web Of Science research areas: Biochemistry & Molecular Biology
ESI research areas: Biology & Biochemistry

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Reward for persistence in substance P research
Creators: C Wahlestedt - Center for Genomics Research, Karolinska Institute, Stockholm, Sweden. Claes.Wahlestedt@cgr.ki.se
Publication Details: Science (American Association for the Advancement of Science), Vol.281(5383), pp.1624-1625
Publisher: United States
Academic Unit: Miller School of Medicine; UMMG Dept of Psychiatry & Behavioral Sciences
Language: English
Resource Type: Journal article
PMID: 9767028
Record Identifier: 991031559612902976